Comparative Efficacy of Non-opioid Analgesic Drugs for Chronic Cancer Pain: A Bayesian Network Meta-analysis.

DrugsJul 9, 2026 (epub)
Clinical ResearchOncology (Medical)Open access

Sebastiano Mercadante, Giovanbattista Vizzini, Alessio Lo Cascio

✦ AI-curated · Sources linked

In 30 seconds

This Bayesian network meta-analysis evaluated the efficacy of non-opioid analgesics for chronic cancer pain in 1845 patients across 23 randomized controlled trials. The study found that nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants had the strongest analgesic effects, with a significant opioid-sparing effect observed for gabapentinoids and ketamine.

Key findings

  • NSAIDs and anticonvulsants showed the most robust analgesic effects with standardized mean differences of -1.10 and -1.06, respectively.
  • The combination of anticonvulsants and antidepressants had the highest probability of efficacy according to SUCRA rankings.
  • Gabapentinoids and ketamine facilitated a significant reduction in morphine equivalent daily dose (MEDD).
  • Minor adverse events like somnolence and dizziness were more frequent in the most effective drug classes.

Why it matters

The findings highlight the potential of non-opioid analgesics to effectively manage chronic cancer pain while minimizing opioid-related toxicities, which is crucial for improving patient quality of life.

Source

Published in Drugs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.